Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery.

Healthpeak Properties

Goldman Sachs analyst David Roman maintained a Hold rating on Doximity today and set a price target of $28.00. Roman covers the Healthcare sector, ...

Doximity (DOCS) Gets a Hold from Goldman Sachs

Convenience store chain Casey’s General Stores ($CASY) will join the coveted S&P 500 (SPX) index at Thursday’s market open, April 9. It replaces Ho...

Casey’s General Stores to Join S&P 500 – What It Means for Shareholders

Insiders have been trading these 5 stocks: (($NBIS)), (($DOCU)), (($OKLO)), (($PDD)) and (($COP)). Here is a breakdown of their recent trades and t...

Nebius, DocuSign, Oklo, PDD, ConocoPhillips Insider Shock

DigitalOcean ($DOCN), the artificial intelligence (AI) underdog, may have more room to run. The company is no longer just a simple cloud provider f...

DigitalOcean Stock (DOCN) Is Up 145% yet this AI Underdog Still Has Room to Run

Teladoc ( ($TDOC) ) has provided an announcement. On March 30, 2026, Teladoc Health, Inc. increased the size of its board of directors to nine memb...

Teladoc Adds Susan Salka to Expanded Board of Directors

In a report released on March 23, Piral Dadhania from RBC Capital maintained a Hold rating on Dr. Martens Plc, with a price target of p100.00. The ...

Dr. Martens Plc (DOCS) Gets a Hold from RBC Capital

In a report released today, Sebastian Vogel from UBS maintained a Sell rating on DocMorris, with a price target of CHF3.50. Vogel covers the Indust...

DocMorris (DOCM) Gets a Sell from UBS

In a report released yesterday, Jan Koch from Deutsche Bank maintained a Hold rating on DocMorris, with a price target of CHF7.00. Koch covers the ...

Deutsche Bank  Keeps Their Hold Rating on DocMorris (DOCM)

UBS analyst Sebastian Vogel maintained a Sell rating on DocMorris today and set a price target of CHF5.00. Vogel covers the Industrials sector, foc...

Barclays analyst Sarah Roberts maintained a Hold rating on DocMorris today and set a price target of CHF6.00. According to TipRanks, Roberts is ran...

Barclays Keeps Their Hold Rating on DocMorris (DOCM)

DocMorris ( ($CH:DOCM) ) has issued an announcement. DocMorris reported that it met its 2025 revenue and earnings targets, delivering double-digit ...

DocMorris Hits 2025 Targets as It Accelerates AI-Driven Health Platform Shift

RBC Capital analyst Rishi Jaluria maintained a Hold rating on DocuSign yesterday and set a price target of $55.00. The company’s shares closed yest...

DocuSign (DOCU) Receives a Hold from RBC Capital

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Circle Internet Group, Inc. Class A (CRCL – Research...

Wall Street Analysts Are Bullish on Top Technology Picks

Docusign ($DOCU) stock ended Tuesday’s session with a 1.54% boost as investors reacted to a strong fourth-quarter performance. The electronic signa...

DOCU Earnings: Docusign Stock Finally Gets a Boost after Reporting a Strong Q4 Beat

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Canopy Growth (CGC – Research Report) and Doximity (...

Analysts Offer Insights on Healthcare Companies: Canopy Growth (CGC) and Doximity (DOCS)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on NeurAxis, Inc. (NRXS – Research Report), Argenx Se (...

Analysts Offer Insights on Healthcare Companies: NeurAxis, Inc. (NRXS), Argenx Se (ARGX) and Teladoc (TDOC)

American software company DocuSign ($DOCU) will release its fourth-quarter fiscal 2026 results after market closes today, March 17. Investors shoul...

DocuSign Q4 Earnings Today – Consensus Expectations and Key KPIs to Watch

On Tuesday, March 17, Lululemon ($LULU), Docusign ($DOCU), and Academy Sports and Outdoors ($ASO) will report their earnings. Academy Sports and Ou...

Polymarket Odds: Will LULU, DOCU, ASO Beat Earnings Tomorrow?

Dr. Martens Plc ( ($GB:DOCS) ) has provided an announcement. Dr. Martens plc has disclosed share transactions by its chief executive officer, Ije N...

Current Quarter	$0.44	Next Quarter	$0.45
Current Year	$1.73	Next Year	$1.78
QoQ Growth	+2.3%	YoY Growth	+2.9%
3Y EPS CAGR	-27.1%	Target Price	$19.43
Consensus	Buy	Upside	+16.4%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DOC	$16.69	0.00%	7.24M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DOC	$16.69	0%	7.24M
3
4
5
6

DOC

DOC

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Healthpeak Properties Data in Excel

Get Healthpeak Properties Data in Excel